Immune Checkpoint Inhibitors for Kidney and Bladder Cancer: Adrenotoxic Consequences. Liblik K, Queen JC, Touma NJ. Urology 2024 Feb 29:S0090-4295(24)00129-8. doi: 10.1016/j.urology.2024.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liblik K, Queen JC, Touma NJ. Immune Checkpoint Inhibitors for Kidney and Bladder Cancer: Adrenotoxic Consequences. Urology 2024 Feb 29:S0090-4295(24)00129-8. doi: 10.1016/j.urology.2024.
PMID: 38431157